AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The recommendation is for the second injection option of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback